Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
The Oncologist|March 14, 2020
"My Research Is Their Business, but I'm Not Their Business": Patient and Clinician Perspectives on Commercialization of Precision Oncology DataKayte Spector-Bagdady, Chris D Krenz, Collin Brummel, et al.
JMIR Cancer|May 3, 2022
Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical AnalysisKayte Spector-Bagdady, Madison Kent, Chris D Krenz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 11, 2019
Patient and Provider Perspectives Regarding Enrollment in Head and Neck Cancer ResearchAndrew G Shuman, Michele C Gornick, Collin Brummel, et al.
Head & Neck|September 18, 2009
Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell linesJ Chad Brenner, Martin P Graham, Bhavna Kumar, et al.
Oral Oncology|February 20, 2022
The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinomaCatherine T Haring, Sarah M Dermody, Pratyusha Yalamanchi, et al.
Molecular Pharmacology|March 13, 2019
Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell CarcinomaNicole L Michmerhuizen, Elizabeth Leonard, Chloe Matovina, et al.
Cancers|October 13, 2021
Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCCJacqueline E Mann, Megan L Ludwig, Aditi Kulkarni, et al.
Health Science Reports|February 28, 2019
Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in GhanaLauren E Merz, Osei Afriyie, Evelyn Jiagge, et al.
Cancer|June 23, 2021
SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancerLisa M Pinatti, Wenjin Gu, Yifan Wang, et al.
American Journal of Clinical Pathology|May 22, 2013
Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumorsScott A Tomlins, Nallasivam Palanisamy, J Chad Brenner, et al.
Pageof 11